Affinity Asset Advisors’s Kymera Therapeutics KYMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-100,000	Closed	-$2.74M	–	97
2025 Q1	$2.74M	Buy	100,000 +60,000	+150%	+$1.64M	0.26%	47
2024 Q4	$1.61M	Buy	+40,000	New	+$1.61M	0.22%	56